Turken, O. Et Al. 2001. Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.. BLOOD , vol.98, no.11 .

Turken, O., Orhan, B., Ozturk, A., ETİZ, D., Yaylaci, M., & Uskent, N., (2001). Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.. BLOOD , vol.98, no.11.

Turken, O Et Al. "Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.," BLOOD , vol.98, no.11, 2001

Turken, O Et Al. "Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.." BLOOD , vol.98, no.11, 2001

Turken, O. Et Al. (2001) . "Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.." BLOOD , vol.98, no.11.

@article{article, author={O Turken Et Al. }, title={Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine, Pentoxifylline, and Ciprofloxacin with Dexamethasone.}, journal={BLOOD}, year=2001}